The global AI Lung Screening System market was valued at US$ 336 million in 2025 and is anticipated to reach US$ 753 million by 2032, at a CAGR of 12.2% from 2026 to 2032.

AI Lung Screening System Market

AI Lung Screening System is an integrated software-driven solution that supports early detection and risk stratification of lung cancer—primarily by analyzing low-dose CT (LDCT) scans in screening or incidental nodule workflows. The system typically performs automated lung nodule detection, segmentation, volumetry, growth tracking, malignancy risk scoring, and structured reporting, aiming to reduce radiologist workload, improve consistency, and standardize follow-up recommendations. In practice, it functions as a clinical decision support layer within radiology operations: it flags suspicious findings, prioritizes worklists, and helps quantify change over time. Commercially, “system” usually refers to a deployable product package (software + workflow integration + validation/regulatory package), rather than an algorithm alone, and is increasingly delivered as a platform with continuous model updates, audit trails, and performance monitoring.

From a multi-angle segmentation standpoint, the market can be parameterized by: (1) Clinical scenario: population LDCT screening vs incidental pulmonary nodules; (2) Algorithmic functions: detection-only, detection+volumetry, full risk scoring (e.g., malignancy probability), and longitudinal tracking; (3) Deployment: on-premise server, private cloud, public cloud/SaaS, or hybrid; (4) Integration depth: standalone viewer vs PACS/RIS embedded workflow with structured reporting; (5) Regulatory class & claims: CAD support vs triage vs quantified decision support. Additional quantitative “type” parameters include supported CT slice thickness, acceptable dose range, nodule size range (e.g., ≥3 mm), sensitivity at fixed false-positive rates, throughput (studies/hour), and interoperability standards (DICOM, HL7/FHIR).

In transaction terms, pricing commonly follows (a) annual subscription per site, (b) per-scan fee, or (c) enterprise license tied to volume tiers, with separate charges for integration, validation support, and service-level agreements. Procurement often runs through hospital IT/security reviews and radiology leadership, with pilots (3–6 months) preceding multi-year contracts. Key trends include tighter workflow embedding (worklist triage + structured reporting), expansion from single-task CAD to end-to-end nodule management, growing emphasis on generalizability and bias control across scanners and populations, and integration of multimodal data (clinical risk factors, prior imaging) to improve risk stratification. As screening volumes rise and radiologist shortages persist, vendors that can prove reduced recall burden, stable false-positive control, and seamless integration are best positioned for durable share gains.

This report delivers a comprehensive overview of the global AI Lung Screening System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding AI Lung Screening System. The AI Lung Screening System market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global AI Lung Screening System market comprehensively. Regional market sizes by Type, by Application, by Imaging Modality & Data Source, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist AI Lung Screening System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of AI Lung Screening System Market Report

Report Metric	Details
Report Name	AI Lung Screening System Market
Accounted market size in 2025	US$ 336 million
Forecasted market size in 2032	US$ 753 million
CAGR	12.2%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Lung Cancer Early Screening Pulmonary Nodule Detection & Tracking High-Risk Population Screening Incidental Lung Finding Screening Others
Segment by Imaging Modality & Data Source	LDCT-based Screening System Standard Chest CT AI System Others
Segment by Deployment & Integration Model	On-premise Private Cloud (Hospital-owned Cloud) Public Cloud / SaaS Others
Segment by Application	Medical Institutions Great Health Scene
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Lunit, Aidoc, VUNO, Inc., Riverain Technologies, LLC, Viz.ai, RapidAI, Enlitic, ANNALISE-AI PTY LTD, INFERVISION TECHNOLOGY, Lianying Intelligent Medical Technology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Imaging Modality & Data Source, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for AI Lung Screening System companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is AI Lung Screening System Market growing?

Ans: The AI Lung Screening System Market witnessing a CAGR of 12.2% during the forecast period 2026-2032.

What is the AI Lung Screening System Market size in 2032?

Ans: The AI Lung Screening System Market size in 2032 will be US$ 753 million.

Who are the main players in the AI Lung Screening System Market report?

Ans: The main players in the AI Lung Screening System Market are Lunit, Aidoc, VUNO, Inc., Riverain Technologies, LLC, Viz.ai, RapidAI, Enlitic, ANNALISE-AI PTY LTD, INFERVISION TECHNOLOGY, Lianying Intelligent Medical Technology

What are the Application segmentation covered in the AI Lung Screening System Market report?

Ans: The Applications covered in the AI Lung Screening System Market report are Medical Institutions, Great Health Scene

What are the Type segmentation covered in the AI Lung Screening System Market report?

Ans: The Types covered in the AI Lung Screening System Market report are Lung Cancer Early Screening, Pulmonary Nodule Detection & Tracking, High-Risk Population Screening, Incidental Lung Finding Screening, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global AI Lung Screening System Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Lung Cancer Early Screening

1.2.3 Pulmonary Nodule Detection & Tracking

1.2.4 High-Risk Population Screening

1.2.5 Incidental Lung Finding Screening

1.2.6 Others

1.3 Market by Imaging Modality & Data Source

1.3.1 Global AI Lung Screening System Market Size Growth Rate by Imaging Modality & Data Source: 2021 vs 2025 vs 2032

1.3.2 LDCT-based Screening System

1.3.3 Standard Chest CT AI System

1.3.4 Others

1.4 Market by Deployment & Integration Model

1.4.1 Global AI Lung Screening System Market Size Growth Rate by Deployment & Integration Model: 2021 vs 2025 vs 2032

1.4.2 On-premise

1.4.3 Private Cloud (Hospital-owned Cloud)

1.4.4 Public Cloud / SaaS

1.4.5 Others

1.5 Market by Application

1.5.1 Global AI Lung Screening System Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Medical Institutions

1.5.3 Great Health Scene

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global AI Lung Screening System Market Perspective (2021–2032)

2.2 Global AI Lung Screening System Growth Trends by Region

2.2.1 Global AI Lung Screening System Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 AI Lung Screening System Historic Market Size by Region (2021–2026)

2.2.3 AI Lung Screening System Forecasted Market Size by Region (2027–2032)

2.3 AI Lung Screening System Market Dynamics

2.3.1 AI Lung Screening System Industry Trends

2.3.2 AI Lung Screening System Market Drivers

2.3.3 AI Lung Screening System Market Challenges

2.3.4 AI Lung Screening System Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top AI Lung Screening System Players by Revenue

3.1.1 Global Top AI Lung Screening System Players by Revenue (2021–2026)

3.1.2 Global AI Lung Screening System Revenue Market Share by Players (2021–2026)

3.2 Global Top AI Lung Screening System Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by AI Lung Screening System Revenue

3.4 Global AI Lung Screening System Market Concentration Ratio

3.4.1 Global AI Lung Screening System Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by AI Lung Screening System Revenue in 2025

3.5 Global Key Players of AI Lung Screening System Head Offices and Areas Served

3.6 Global Key Players of AI Lung Screening System, Products and Applications

3.7 Global Key Players of AI Lung Screening System, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 AI Lung Screening System Breakdown Data by Type

4.1 Global AI Lung Screening System Historic Market Size by Type (2021–2026)

4.2 Global AI Lung Screening System Forecasted Market Size by Type (2027–2032)

5 AI Lung Screening System Breakdown Data by Application

5.1 Global AI Lung Screening System Historic Market Size by Application (2021–2026)

5.2 Global AI Lung Screening System Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America AI Lung Screening System Market Size (2021–2032)

6.2 North America AI Lung Screening System Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America AI Lung Screening System Market Size by Country (2021–2026)

6.4 North America AI Lung Screening System Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe AI Lung Screening System Market Size (2021–2032)

7.2 Europe AI Lung Screening System Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe AI Lung Screening System Market Size by Country (2021–2026)

7.4 Europe AI Lung Screening System Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific AI Lung Screening System Market Size (2021–2032)

8.2 Asia-Pacific AI Lung Screening System Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific AI Lung Screening System Market Size by Region (2021–2026)

8.4 Asia-Pacific AI Lung Screening System Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America AI Lung Screening System Market Size (2021–2032)

9.2 Latin America AI Lung Screening System Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America AI Lung Screening System Market Size by Country (2021–2026)

9.4 Latin America AI Lung Screening System Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa AI Lung Screening System Market Size (2021–2032)

10.2 Middle East & Africa AI Lung Screening System Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa AI Lung Screening System Market Size by Country (2021–2026)

10.4 Middle East & Africa AI Lung Screening System Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Lunit

11.1.1 Lunit Company Details

11.1.2 Lunit Business Overview

11.1.3 Lunit AI Lung Screening System Introduction

11.1.4 Lunit Revenue in AI Lung Screening System Business (2021–2026)

11.1.5 Lunit Recent Development

11.2 Aidoc

11.2.1 Aidoc Company Details

11.2.2 Aidoc Business Overview

11.2.3 Aidoc AI Lung Screening System Introduction

11.2.4 Aidoc Revenue in AI Lung Screening System Business (2021–2026)

11.2.5 Aidoc Recent Development

11.3 VUNO, Inc.

11.3.1 VUNO, Inc. Company Details

11.3.2 VUNO, Inc. Business Overview

11.3.3 VUNO, Inc. AI Lung Screening System Introduction

11.3.4 VUNO, Inc. Revenue in AI Lung Screening System Business (2021–2026)

11.3.5 VUNO, Inc. Recent Development

11.4 Riverain Technologies, LLC

11.4.1 Riverain Technologies, LLC Company Details

11.4.2 Riverain Technologies, LLC Business Overview

11.4.3 Riverain Technologies, LLC AI Lung Screening System Introduction

11.4.4 Riverain Technologies, LLC Revenue in AI Lung Screening System Business (2021–2026)

11.4.5 Riverain Technologies, LLC Recent Development

11.5 Viz.ai

11.5.1 Viz.ai Company Details

11.5.2 Viz.ai Business Overview

11.5.3 Viz.ai AI Lung Screening System Introduction

11.5.4 Viz.ai Revenue in AI Lung Screening System Business (2021–2026)

11.5.5 Viz.ai Recent Development

11.6 RapidAI

11.6.1 RapidAI Company Details

11.6.2 RapidAI Business Overview

11.6.3 RapidAI AI Lung Screening System Introduction

11.6.4 RapidAI Revenue in AI Lung Screening System Business (2021–2026)

11.6.5 RapidAI Recent Development

11.7 Enlitic

11.7.1 Enlitic Company Details

11.7.2 Enlitic Business Overview

11.7.3 Enlitic AI Lung Screening System Introduction

11.7.4 Enlitic Revenue in AI Lung Screening System Business (2021–2026)

11.7.5 Enlitic Recent Development

11.8 ANNALISE-AI PTY LTD

11.8.1 ANNALISE-AI PTY LTD Company Details

11.8.2 ANNALISE-AI PTY LTD Business Overview

11.8.3 ANNALISE-AI PTY LTD AI Lung Screening System Introduction

11.8.4 ANNALISE-AI PTY LTD Revenue in AI Lung Screening System Business (2021–2026)

11.8.5 ANNALISE-AI PTY LTD Recent Development

11.9 INFERVISION TECHNOLOGY

11.9.1 INFERVISION TECHNOLOGY Company Details

11.9.2 INFERVISION TECHNOLOGY Business Overview

11.9.3 INFERVISION TECHNOLOGY AI Lung Screening System Introduction

11.9.4 INFERVISION TECHNOLOGY Revenue in AI Lung Screening System Business (2021–2026)

11.9.5 INFERVISION TECHNOLOGY Recent Development

11.10 Lianying Intelligent Medical Technology

11.10.1 Lianying Intelligent Medical Technology Company Details

11.10.2 Lianying Intelligent Medical Technology Business Overview

11.10.3 Lianying Intelligent Medical Technology AI Lung Screening System Introduction

11.10.4 Lianying Intelligent Medical Technology Revenue in AI Lung Screening System Business (2021–2026)

11.10.5 Lianying Intelligent Medical Technology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Infervision Technology

Lianying Intelligent Medical Technology

Lunit

Aidoc

VUNO

Riverain Technologies, LLC

List of Tables

Table 1. Global AI Lung Screening System Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Lung Cancer Early Screening

Table 3. Key Players of Pulmonary Nodule Detection & Tracking

Table 4. Key Players of High-Risk Population Screening

Table 5. Key Players of Incidental Lung Finding Screening

Table 6. Key Players of Others

Table 7. Global AI Lung Screening System Market Size Growth Rate by Imaging Modality & Data Source (US$ Million): 2021 vs 2025 vs 2032

Table 8. Key Players of LDCT-based Screening System

Table 9. Key Players of Standard Chest CT AI System

Table 10. Key Players of Others

Table 11. Global AI Lung Screening System Market Size Growth Rate by Deployment & Integration Model (US$ Million): 2021 vs 2025 vs 2032

Table 12. Key Players of On-premise

Table 13. Key Players of Private Cloud (Hospital-owned Cloud)

Table 14. Key Players of Public Cloud / SaaS

Table 15. Key Players of Others

Table 16. Global AI Lung Screening System Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global AI Lung Screening System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 18. Global AI Lung Screening System Market Size by Region (US$ Million), 2021–2026

Table 19. Global AI Lung Screening System Market Share by Region (2021–2026)

Table 20. Global AI Lung Screening System Forecasted Market Size by Region (US$ Million), 2027–2032

Table 21. Global AI Lung Screening System Market Share by Region (2027–2032)

Table 22. AI Lung Screening System Market Trends

Table 23. AI Lung Screening System Market Drivers

Table 24. AI Lung Screening System Market Challenges

Table 25. AI Lung Screening System Market Restraints

Table 26. Global AI Lung Screening System Revenue by Players (US$ Million), 2021–2026

Table 27. Global AI Lung Screening System Market Share by Players (2021–2026)

Table 28. Global Top AI Lung Screening System Players by Tier (Tier 1, Tier 2, and Tier 3), based on AI Lung Screening System Revenue, 2025

Table 29. Ranking of Global Top AI Lung Screening System Companies by Revenue (US$ Million) in 2025

Table 30. Global 5 Largest Players Market Share by AI Lung Screening System Revenue (CR5 and HHI), 2021–2026

Table 31. Global Key Players of AI Lung Screening System, Headquarters and Area Served

Table 32. Global Key Players of AI Lung Screening System, Products and Applications

Table 33. Global Key Players of AI Lung Screening System, Date of General Availability (GA)

Table 34. Mergers and Acquisitions, Expansion Plans

Table 35. Global AI Lung Screening System Market Size by Type (US$ Million), 2021–2026

Table 36. Global AI Lung Screening System Revenue Market Share by Type (2021–2026)

Table 37. Global AI Lung Screening System Forecasted Market Size by Type (US$ Million), 2027–2032

Table 38. Global AI Lung Screening System Revenue Market Share by Type (2027–2032)

Table 39. Global AI Lung Screening System Market Size by Application (US$ Million), 2021–2026

Table 40. Global AI Lung Screening System Revenue Market Share by Application (2021–2026)

Table 41. Global AI Lung Screening System Forecasted Market Size by Application (US$ Million), 2027–2032

Table 42. Global AI Lung Screening System Revenue Market Share by Application (2027–2032)

Table 43. North America AI Lung Screening System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. North America AI Lung Screening System Market Size by Country (US$ Million), 2021–2026

Table 45. North America AI Lung Screening System Market Size by Country (US$ Million), 2027–2032

Table 46. Europe AI Lung Screening System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 47. Europe AI Lung Screening System Market Size by Country (US$ Million), 2021–2026

Table 48. Europe AI Lung Screening System Market Size by Country (US$ Million), 2027–2032

Table 49. Asia-Pacific AI Lung Screening System Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 50. Asia-Pacific AI Lung Screening System Market Size by Region (US$ Million), 2021–2026

Table 51. Asia-Pacific AI Lung Screening System Market Size by Region (US$ Million), 2027–2032

Table 52. Latin America AI Lung Screening System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 53. Latin America AI Lung Screening System Market Size by Country (US$ Million), 2021–2026

Table 54. Latin America AI Lung Screening System Market Size by Country (US$ Million), 2027–2032

Table 55. Middle East & Africa AI Lung Screening System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 56. Middle East & Africa AI Lung Screening System Market Size by Country (US$ Million), 2021–2026

Table 57. Middle East & Africa AI Lung Screening System Market Size by Country (US$ Million), 2027–2032

Table 58. Lunit Company Details

Table 59. Lunit Business Overview

Table 60. Lunit AI Lung Screening System Product

Table 61. Lunit Revenue in AI Lung Screening System Business (US$ Million), 2021–2026

Table 62. Lunit Recent Development

Table 63. Aidoc Company Details

Table 64. Aidoc Business Overview

Table 65. Aidoc AI Lung Screening System Product

Table 66. Aidoc Revenue in AI Lung Screening System Business (US$ Million), 2021–2026

Table 67. Aidoc Recent Development

Table 68. VUNO, Inc. Company Details

Table 69. VUNO, Inc. Business Overview

Table 70. VUNO, Inc. AI Lung Screening System Product

Table 71. VUNO, Inc. Revenue in AI Lung Screening System Business (US$ Million), 2021–2026

Table 72. VUNO, Inc. Recent Development

Table 73. Riverain Technologies, LLC Company Details

Table 74. Riverain Technologies, LLC Business Overview

Table 75. Riverain Technologies, LLC AI Lung Screening System Product

Table 76. Riverain Technologies, LLC Revenue in AI Lung Screening System Business (US$ Million), 2021–2026

Table 77. Riverain Technologies, LLC Recent Development

Table 78. Viz.ai Company Details

Table 79. Viz.ai Business Overview

Table 80. Viz.ai AI Lung Screening System Product

Table 81. Viz.ai Revenue in AI Lung Screening System Business (US$ Million), 2021–2026

Table 82. Viz.ai Recent Development

Table 83. RapidAI Company Details

Table 84. RapidAI Business Overview

Table 85. RapidAI AI Lung Screening System Product

Table 86. RapidAI Revenue in AI Lung Screening System Business (US$ Million), 2021–2026

Table 87. RapidAI Recent Development

Table 88. Enlitic Company Details

Table 89. Enlitic Business Overview

Table 90. Enlitic AI Lung Screening System Product

Table 91. Enlitic Revenue in AI Lung Screening System Business (US$ Million), 2021–2026

Table 92. Enlitic Recent Development

Table 93. ANNALISE-AI PTY LTD Company Details

Table 94. ANNALISE-AI PTY LTD Business Overview

Table 95. ANNALISE-AI PTY LTD AI Lung Screening System Product

Table 96. ANNALISE-AI PTY LTD Revenue in AI Lung Screening System Business (US$ Million), 2021–2026

Table 97. ANNALISE-AI PTY LTD Recent Development

Table 98. INFERVISION TECHNOLOGY Company Details

Table 99. INFERVISION TECHNOLOGY Business Overview

Table 100. INFERVISION TECHNOLOGY AI Lung Screening System Product

Table 101. INFERVISION TECHNOLOGY Revenue in AI Lung Screening System Business (US$ Million), 2021–2026

Table 102. INFERVISION TECHNOLOGY Recent Development

Table 103. Lianying Intelligent Medical Technology Company Details

Table 104. Lianying Intelligent Medical Technology Business Overview

Table 105. Lianying Intelligent Medical Technology AI Lung Screening System Product

Table 106. Lianying Intelligent Medical Technology Revenue in AI Lung Screening System Business (US$ Million), 2021–2026

Table 107. Lianying Intelligent Medical Technology Recent Development

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. AI Lung Screening System Picture

Figure 2. Global AI Lung Screening System Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global AI Lung Screening System Market Share by Type: 2025 vs 2032

Figure 4. Lung Cancer Early Screening Features

Figure 5. Pulmonary Nodule Detection & Tracking Features

Figure 6. High-Risk Population Screening Features

Figure 7. Incidental Lung Finding Screening Features

Figure 8. Others Features

Figure 9. Global AI Lung Screening System Market Size Comparison by Imaging Modality & Data Source (US$ Million), 2021–2032

Figure 10. LDCT-based Screening System Features

Figure 11. Standard Chest CT AI System Features

Figure 12. Others Features

Figure 13. Global AI Lung Screening System Market Size Comparison by Deployment & Integration Model (US$ Million), 2021–2032

Figure 14. On-premise Features

Figure 15. Private Cloud (Hospital-owned Cloud) Features

Figure 16. Public Cloud / SaaS Features

Figure 17. Others Features

Figure 18. Global AI Lung Screening System Market Size by Application (US$ Million), 2021–2032

Figure 19. Global AI Lung Screening System Market Share by Application: 2025 vs 2032

Figure 20. Medical Institutions Case Studies

Figure 21. Great Health Scene Case Studies

Figure 22. AI Lung Screening System Report Years Considered

Figure 23. Global AI Lung Screening System Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 24. Global AI Lung Screening System Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 25. Global AI Lung Screening System Market Share by Region: 2025 vs 2032

Figure 26. Global AI Lung Screening System Market Share by Players in 2025

Figure 27. Global AI Lung Screening System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 28. The Top 10 and 5 Players Market Share by AI Lung Screening System Revenue in 2025

Figure 29. North America AI Lung Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. North America AI Lung Screening System Market Share by Country (2021–2032)

Figure 31. United States AI Lung Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Canada AI Lung Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Europe AI Lung Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Europe AI Lung Screening System Market Share by Country (2021–2032)

Figure 35. Germany AI Lung Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. France AI Lung Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. U.K. AI Lung Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Italy AI Lung Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Russia AI Lung Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Ireland AI Lung Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Asia-Pacific AI Lung Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Asia-Pacific AI Lung Screening System Market Share by Region (2021–2032)

Figure 43. China AI Lung Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Japan AI Lung Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. South Korea AI Lung Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Southeast Asia AI Lung Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. India AI Lung Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Australia & New Zealand AI Lung Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Latin America AI Lung Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Latin America AI Lung Screening System Market Share by Country (2021–2032)

Figure 51. Mexico AI Lung Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Brazil AI Lung Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. Middle East & Africa AI Lung Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Middle East & Africa AI Lung Screening System Market Share by Country (2021–2032)

Figure 55. Israel AI Lung Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. Saudi Arabia AI Lung Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 57. UAE AI Lung Screening System Market Size YoY Growth (US$ Million), 2021–2032

Figure 58. Lunit Revenue Growth Rate in AI Lung Screening System Business (2021–2026)

Figure 59. Aidoc Revenue Growth Rate in AI Lung Screening System Business (2021–2026)

Figure 60. VUNO, Inc. Revenue Growth Rate in AI Lung Screening System Business (2021–2026)

Figure 61. Riverain Technologies, LLC Revenue Growth Rate in AI Lung Screening System Business (2021–2026)

Figure 62. Viz.ai Revenue Growth Rate in AI Lung Screening System Business (2021–2026)

Figure 63. RapidAI Revenue Growth Rate in AI Lung Screening System Business (2021–2026)

Figure 64. Enlitic Revenue Growth Rate in AI Lung Screening System Business (2021–2026)

Figure 65. ANNALISE-AI PTY LTD Revenue Growth Rate in AI Lung Screening System Business (2021–2026)

Figure 66. INFERVISION TECHNOLOGY Revenue Growth Rate in AI Lung Screening System Business (2021–2026)

Figure 67. Lianying Intelligent Medical Technology Revenue Growth Rate in AI Lung Screening System Business (2021–2026)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global AI Cardiovascular Screening System Market Research Report 2024

Global AI Eye Screening System Market Research Report 2024

Global Lung AI assisted Diagnosis Solution Market Research Report 2024

Global Lung AI assisted Diagnosis Software Market Research Report 2024

Global AI Bone Screening System Market Research Report 2024

Global Artificial Intelligence Cardiovascular Screening System Market Research Report 2024

Global AI Head and Neck Screening System Market Research Report 2024

Global Artificial Intelligence Bone Screening System Market Research Report 2024

Global AI Surveillance System Market Research Report 2024

Global Lung Cancer Screening Software Market Research Report 2024

Global AI Medical Solutions Market Research Report 2025

Global AI Medical Product Market Research Report 2024

Global Medical and Health AI Product Market Research Report 2024

Global AI Medical Imaging Product Market Research Report 2024

Global AI OCRs Market Research Report 2024

Global Artificial Intelligence Head and Neck Screening System Market Research Report 2024

Global AI Detection Tool Market Research Report 2024

Global Air Screening Machine Market Research Report 2025

Global AI Computer Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions